Monogram Orthopaedics (NASDAQ:MGRM) Announces Quarterly Earnings Results, Misses Estimates By $0.02 EPS

Monogram Orthopaedics (NASDAQ:MGRM) announced its quarterly earnings results on Thursday. The company reported ($0.11) EPS for the quarter, missing analysts’ consensus estimates of ($0.09) by ($0.02), Zacks reports. During the same period last year, the firm earned ($0.27) earnings per share.

Monogram Orthopaedics Stock Performance

Shares of NASDAQ MGRM traded up $0.03 during mid-day trading on Friday, hitting $2.82. The stock had a trading volume of 62,426 shares, compared to its average volume of 122,295. The business has a 50 day moving average price of $2.27 and a two-hundred day moving average price of $2.38. Monogram Orthopaedics has a 1 year low of $1.53 and a 1 year high of $5.15. The firm has a market cap of $89.31 million, a P/E ratio of -5.64 and a beta of 2.21.

About Monogram Orthopaedics

Monogram Orthopaedics, Inc focuses on developing a product solution architecture to enable patient-optimized orthopaedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures.